EVEREST MED(01952),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01952 EVEREST MED

Not Yet Opened 09-03 16:08:21

32.480

+0.260

+0.81%

High33.300	Low32.100	Vol5.89M
Open32.500	D1 Closing32.220	Amplitude3.72%
Mkt Cap11.50B	Tradable Cap11.50B	Total Shares354.00M
T/O192.15M	T/O Rate1.66%	Tradable Shares354.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01952","market":"HK","secType":"STK","nameCN":"EVEREST MED","latestPrice":32.48,"timestamp":1788422901001,"preClose":32.22,"halted":0,"volume":5889056,"delay":0,"changeRate":0.00806952203600242,"floatShares":354000000,"shares":354000000,"eps":-0.89,"marketStatus":"Not Yet Opened","change":0.26,"latestTime":"09-03 16:08:21","open":32.5,"high":33.3,"low":32.1,"amount":192148639,"amplitude":0.037244,"askPrice":32.48,"askSize":2000,"bidPrice":32.42,"bidSize":145500,"shortable":3,"etf":0,"ttmEps":-0.175,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788485400000},"marketStatusCode":0,"adr":0,"listingDate":1602172800000,"exchange":"SEHK","adjPreClose":32.22,"openAndCloseTimeList":[[1788399000000,1788408000000],[1788411600000,1788422400000]],"volumeRatio":0.509307,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01952/wiki","defaultTab":"wiki","newsList":[{"id":"2664480867","title":"Milestone Pharmaceuticals Says NMPA Approval Triggers $2 Mln Milestone Payment to the Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2664480867","media":"Reuters","labels":["corporation","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664480867?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:56","pubTimestamp":1788447419,"startTime":"0","endTime":"0","summary":"Sept 3 (Reuters) - Milestone Pharmaceuticals Inc::*MILESTONE PHARMACEUTICALS ANNOUNCES NMPA APPROVAL OF ETRIPAMIL NASAL SPRAY FOR PSVT IN CHINA, MARKING FIRST REGULATORY APPROVAL OF ETRIPAMIL OUTSIDE ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nRSD1Mvfn1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","MIST","01952","BK4007","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874018","title":"Everest Medicines Gets China Nod for CARDAMYST Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874018","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874018?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:40","pubTimestamp":1788439214,"startTime":"0","endTime":"0","summary":"Everest Medicines  obtained approval for the new drug application of CARDAMYST from China's National Medical Products Administration.The drug is for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia to sinus rhythm in adults, according to a Thursday Hong Kong bourse filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","01952","MDCO","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195359122","title":"EVEREST MED Wins NMPA Approval for CARDAMYST Nasal Spray, First Self-Administered Treatment for Adult PSVT in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1195359122","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195359122?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:22","pubTimestamp":1788438163,"startTime":"0","endTime":"0","summary":"Hong Kong, 3 September 2026 — Everest Medicines Limited (EVEREST MED) has obtained National Medical Products Administration (NMPA) clearance for its New Drug Application (NDA) for CARDAMYST...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664087437","title":"Everest Medicines Says China NMPA Approves Cardamyst Nasal Spray for PSVT Conversion in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2664087437","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664087437?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:15","pubTimestamp":1788437722,"startTime":"0","endTime":"0","summary":"Everest Medicines says China NMPA approves Cardamyst nasal spray for PSVT conversion in adultsChina’s NMPA cleared the NDA for CARDAMYST (etripamil) nasal spray to convert acute PSVT episodes to sinus","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDLbRghy4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1583","01952","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664871033","title":"Everest Medicines - Nmpa Approves Cardamyst (Etripamil) Nda for Psvt in Adults in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2664871033","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664871033?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:06","pubTimestamp":1788437196,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V0KG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1574","01952","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152809628","title":"EVEREST MED's pioneering cardiovascular treatment receives green light in China, introducing the first and only on-demand rescue therapy for adults with PSVT","url":"https://stock-news.laohu8.com/highlight/detail?id=1152809628","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152809628?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:50","pubTimestamp":1788425447,"startTime":"0","endTime":"0","summary":"On September 3rd, Hong Kong-listed innovative drug developer EVEREST MED (01952) announced that China's National Medical Products Administration (NMPA) has approved the New Drug Application (NDA) for...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","BK1574","HRTS","01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181333407","title":"Movement Alert｜EVEREST MED Rises 6.56% in Regular Trading, Rebounding After Recent Profit-Taking as mRNA Biotech Sector Recovers","url":"https://stock-news.laohu8.com/highlight/detail?id=1181333407","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181333407?lang=en_us&edition=fundamental","pubTime":"2026-09-02 09:35","pubTimestamp":1788312947,"startTime":"0","endTime":"0","summary":"On September 2, EVEREST MED rose 6.56% in regular trading, trading at 34.58 HKD/share, with turnover of 84.25 million HKD. The stock rebounded sharply after declining 6.29% on August 31, when prior...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"EVEREST MED Surges as Nefecon H1 Sales Hit RMB 889M","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122897904","title":"Movement Alert｜EVEREST MED Falls 5.19% in Regular Trading, mRNA Concept Pullback and Biotech Sector Weakness Weigh on Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1122897904","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122897904?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:09","pubTimestamp":1788142185,"startTime":"0","endTime":"0","summary":"On August 31, EVEREST MED fell 5.19% in regular trading, trading at HK$33.0/share, with turnover of HK$108 million.The decline extends the ongoing retreat in mRNA-concept stocks and broader biotech...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"EVEREST MED Slumps as mRNA Vaccine Rally Unwinds","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173600020","title":"Movement Alert｜EVEREST MED Falls 5.2% in Regular Trading, mRNA Concept Sentiment Cooling and Sector Weakness Trigger Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=1173600020","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173600020?lang=en_us&edition=fundamental","pubTime":"2026-08-28 14:54","pubTimestamp":1787900085,"startTime":"0","endTime":"0","summary":"On August 28, EVEREST MED fell 5.2% in regular trading to HK$34.96, with turnover of HK$325 million. The decline was driven by fading enthusiasm for the mRNA concept and broad weakness across the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BOCOM Keeps Buy on EVEREST MED as mRNA Rally Fades","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165133516","title":"Movement Alert｜EVEREST MED Rises 5.16% in Regular Trading, mRNA Momentum and Strong Earnings Continue to Fuel Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1165133516","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165133516?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:31","pubTimestamp":1787707887,"startTime":"0","endTime":"0","summary":"On August 26, EVEREST MED rose 5.16% in regular trading, trading at HK$38.88/share, with turnover of HK$68.90 million. The stock continues its upward trajectory following a multi-day rally driven by...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"EVEREST MED Rises as BOCOM Keeps Buy, Nefecon Sales Up 94%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102179577","title":"Market Sentiment Stabilizes as Sanctions Prove Largely Symbolic; Tech Benchmarks Surge on Potential Dovish Fed Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=1102179577","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102179577?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:03","pubTimestamp":1787659392,"startTime":"0","endTime":"0","summary":"Market dynamics took a surprising turn today as the harsh \"devastating\" sanctions threatened by the U.S. yesterday turned out to be more bark than bite. A-shares closed higher while Hong Kong stocks...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1852331112.SGD","SMH","SG9999001424.SGD","SG9999014559.SGD","NVDU","LU0823434740.USD","ESUM","LU0069063385.USD","LU2471134796.USD","LU0630378429.USD","BK4614","BK4551","LU2471134523.USD","LU0211328371.USD","BK4581","LU2272731865.HKD","LU0251143458.SGD","LU0880133367.SGD","LU2461242641.AUD","01548","01316","LU2476274308.USD","SG9999014906.USD","LU1267930490.SGD","LU2294711713.HKD","BK4548","LU2351347302.SGD","SG9999004220.SGD","LU1691799644.USD","01057","LU0516423174.USD","SG9999014898.SGD","LU0724617625.USD","BIDU","LU0215105999.USD","LU1400636491.USD","ONLN","CHAT","CLIX","LU2237443465.HKD","LU2487616109.SGD","IE00BMPRXR70.SGD","LU2456880835.USD","BK1516","LU0077335932.USD","BK4605","BK4505","LU1496350502.SGD","LU0197773673.USD","LU0072462343.USD","BK1521","LU2756315664.SGD","ROM","LU1861220033.SGD","LU2488822045.USD","LU1880398554.USD","ANV","LU2290526834.HKD","LU0289961442.SGD","SGXZ51526630.SGD","LU0797268264.HKD","BBYY","BK1574","NVC","LU0820561818.USD","LU1917777945.USD","IE0034235188.USD","BK4543","LU0494093205.USD","IE00BFSS8Q28.SGD","LU0157215616.USD","LU0965508806.USD","01888","NVDQ","LU2471134879.HKD","LU0326950275.SGD","LU0133085943.USD","LU2065170008.USD","LU0856984785.SGD","LU1623119135.USD","LU2491049909.HKD","LU0683600562.USD","LU0823414478.USD","LU2237957811.SGD","LU1935042488.USD","LU2360032135.SGD","LU2249611893.SGD","LU1115378108.SGD","LU0488056044.USD","LU2896262040.SGD","SNPE","IE00BWXC8680.SGD","SG9999015952.SGD","LU0227179875.USD","TYLG","LU1951200564.SGD","LU1282648689.USD","06869","LU0456842615.SGD","LU0661504455.SGD","BK1132","LU1366333091.USD","NVD","002703","LU1923622614.USD","LU2602419157.SGD","LU0417516738.SGD","HK0000304805.HKD","IE00BKVL7J92.USD","HK0000320264.USD","LU2083900584.USD","BK4550","LU1934455194.USD","TEK","LU0348825331.USD","LU0882574139.USD","SGXZ80539844.SGD","LU1232071149.USD","LU2108987350.USD","LU1934455277.USD","LU2264538146.SGD","LU0823414551.USD","LU1267930227.SGD","IE0004091025.USD","LU1037948541.HKD","SG9999014880.SGD","LU0310800379.SGD","LU2242649171.HKD","LU1244550221.USD","09888","BK4579","LU0345770993.USD","LU1688375341.USD","LU1282649141.HKD","LU1035775433.USD","IE00BYXW3230.USD","LU2360107168.USD","HK0000914660.USD","LU0417517546.SGD","LU2125909759.SGD","LU0868494708.USD","LU0327786744.USD","KBAB","07388","TRFK","LU0072462426.USD","SG9999014542.SGD","LU0823421416.USD","LU2236285917.USD","LU0395794307.EUR","BK4585","LU0795875169.SGD","IE00B4YYXB79.USD","BK4567","LU0819121731.USD","LU2125909247.SGD","LU1023057109.AUD","KBDCY","LU1064131342.USD","LU1242518857.USD","LU2191332357.HKD","LU0642271901.SGD","LU1048588211.SGD","LU1435385759.SGD","BK1576","LU0957791311.USD","LU1989764664.SGD","LU0274383008.USD","LU0029874061.USD","LU0345768153.USD","LU0788109477.HKD","LU1732799900.SGD","SOXQ","GAMR","IE000W1ABFV2.USD","AIPI","LU0572944931.SGD","LU0456846285.SGD","LU1066051811.HKD","LU1051769294.HKD","LU1144417596.USD","NVDL","LU0353189763.USD","LU2247934214.USD","LU1323610961.USD","BK1587","LU2361044949.HKD","LU0912757837.SGD","LU0640798160.USD","IE00B5TLWC47.USD","LU0545039389.USD","LU1267930730.SGD","LU2237443382.USD","LU0345770308.USD","LU0708995401.HKD","BK4558","SHOC","AIFD","LU1244550577.SGD","LU2168564222.USD","LU2746668461.USD","LU2347655073.USD","LU0417516902.SGD","IE0034235303.USD","SG9999014914.USD","LU0127658192.USD","LU0289960550.SGD","LU0823426480.USD","BK4565","LU0081259029.USD","LU1496350171.SGD","LU0203201768.USD","LU0762540952.USD","LU1769817179.HKD","LU0323591593.USD","BK1518","BK4529","LU0323240290.USD","00148","LU1808992512.USD","LU2100268510.USD","LU0820561909.HKD","BK1109","LU0456827905.SGD","SPTE","IE000KEQY171.SGD","LU1571399168.USD","LU2063271972.USD","LU2092627202.USD","LU1211504680.USD","IE00BD6J9T35.USD","LU0234570918.USD","IE000ITXATA3.USD","IE0003U64NQ7.SGD","IE0034224299.USD","LU0466842654.USD","LU1831875114.USD","NVDA","SNVD.UK","BK1506","AGOX","LU1823568750.SGD","IE00B7KXQ091.USD","LU0229945570.USD","LU0094547139.USD","LU0096362180.USD","LU0787776722.HKD","BK4534","LU2271345857.HKD","LU2430703178.SGD","LU1815336760.USD","LU0052750758.USD","LU2458330243.SGD","SG9999002828.SGD","LU0057025933.USD","LU2505996509.AUD","LU1815333072.USD","LU2357305700.SGD","LU1202635105.USD","LU2999663052.SGD","MCHS","LU2272731600.USD","IE00B4JS1V06.HKD","BK1609","LU2213496289.HKD","09995","LU2750360641.GBP","LU1328615791.USD","LU0109392836.USD","LU1127390331.HKD","LU0143551892.USD","LU0942090050.USD","SG9999014567.USD","USXF","LU2097344357.USD","SNVDA2609","LU1008478684.HKD","IE00B19Z8X17.USD","LU1244550494.USD","LU2328871848.SGD","LU2357125470.USD","SOXY","LU0228367735.SGD","IE00BDCRKT87.USD","LU0225283273.USD","LU0965509283.SGD","LU2552382132.HKD","LU1551013425.SGD","LU1235294995.USD","LU1992135472.HKD","BK1095","LU0124676726.USD","LU1935043536.SGD","688428","LU2360106780.USD","HK0000320223.HKD","LU1152091754.HKD","LU0315179316.USD","LU1066053197.SGD","LU1720051108.HKD","LU0871576103.HKD","LU2187417386.USD","LU0726765562.USD","LU2491050071.SGD","LU1699723380.USD","LU0943347566.SGD","EFIV","LU1242518931.SGD","LU2265009873.SGD","TCHI","LU0067412154.USD","IE00B5949003.HKD","IE00BQXX3C00.GBP","HK0000306701.USD","LU0203202063.USD","LU2047632596.USD","NVDX","SG9999015341.SGD","2NVD.UK","LU0107464264.USD","IE0005OL40V9.USD","LU0516422952.EUR","LU0354030511.USD","ESLG","LU0511384066.AUD","SG9999002463.SGD","09988","CLSE","LU1400636657.SGD","LU0310800965.SGD","IE00B3M56506.USD","06821","NVDG","NVDS","LU0348723411.USD","LU0175139822.USD","LU2089985449.USD","SGXZ31699556.SGD","LU1048596156.SGD","LU0347712357.USD","LU1084165304.USD","LU0029864427.USD","SGXZ99366536.SGD","LU0210536198.USD","LU2065171402.SGD","BK1161","LU1066051498.USD","BK4608","BK4141","LU2552382215.SGD","09969","LU0079474960.USD","LU1732800096.USD","BK4554","LU0158827781.USD","LU0345768740.USD","LU0348816934.USD","DRAG","LU2347655156.SGD","BK4502","BABO","LU0043850808.USD","LU0061475181.USD","LU0163747925.USD","LU0965509010.AUD","LU1988902786.USD","IE00B775H168.HKD","HK0000304797.USD","LU2473716301.USD","BK1519","LU1814569148.SGD","LU2491050154.USD","IE0009356076.USD","LU0106959298.USD","LU0708995583.HKD","IE000Q6AESB8.SGD","LU1145028129.USD","LU0096364046.USD","LU0861579265.USD","LU1868836757.USD","IE00BK4W5M84.HKD","LU0342679015.USD","SGXZ23171101.USD","IE0004445239.USD","LU0051755006.USD","LU0244354667.USD","IE00B19Z9505.USD","LU1868837136.USD","NVDO","LU1551013342.USD","LU0384037296.USD","LU1267930573.SGD","LU2286300806.USD","LU2092937148.SGD","LU0672654240.SGD","NVDW","LU2505996681.GBP","LU0354030438.USD","LU0979878070.USD","LU1119994496.HKD","LU0198837287.USD","LU0516422440.USD","BK1149","LU2097344431.USD","LU2860962120.EUR","LU2087621335.USD","BK4122","LU1791710400.SGD","LU1153585028.USD","LU2420271590.USD","BABU","LU0158827948.USD","SNVDAmain","LU0056508442.USD","LU1989772840.SGD","LU0444971666.USD","LU1992135399.USD","LU0359201885.HKD","LU2637965513.SGD","LU0238689110.USD","LU1645745479.HKD","ARTY","LU0868494617.USD","LU0187121727.USD","LU1282649810.SGD","METV","LU0310799852.SGD","BK4592","SG9999002232.USD","LU2125154778.USD","LU0949170772.SGD","LU2506951792.HKD","LU1934455863.HKD","BK4220","LU0170899867.USD","LU1804176565.USD","IE0001KFT4U8.USD","LU0109391861.USD","LU1316542783.SGD","IE00B1BXHZ80.USD","LU0287142896.SGD","LU0964807845.USD","LU2552382058.USD","LU0708994859.HKD","IE00BKPKM429.USD","IE00BMPRXN33.USD","LU0256863902.USD","LU2244417387.USD","LU2471134952.CNY","IE0034235295.USD","LU1069344957.HKD","THMR","BK4598","HK0000819398.USD","LU0651946864.USD","LU2242650005.HKD","LU2458330169.SGD","FTEC","LU0528227936.USD","TTXU","LU1116320901.HKD","LU0138981039.USD","LU2543165471.USD","LU0181495838.USD","HK0000914686.HKD","LU1366192091.USD","LU2452424414.USD","LU0762541174.USD","LU0097036916.USD","LU0106261372.USD","LU1116320737.USD","LU3063872942.SGD","LU2250418816.HKD","BK4526","IE00BZ199S13.USD","LU0052756011.USD","SG9999014575.USD","SG9999015358.SGD","LU2237957902.USD","LU0823426308.USD","LU1979441026.SGD","LU2089284900.SGD","LU0557290698.USD","LU1923623000.USD","LU0256863811.USD","IE00BF5LJ272.USD","IE00BJJMRY28.SGD","IE00B3S45H60.SGD","LU2125909593.SGD","FPA","IE00BKDWB100.SGD","601869","BK4607","LU0211977185.USD","LU2023251221.USD","BK4587","DIPS","LU0348814723.USD","LU1280957306.USD","LU0820562030.AUD","NVDD","SG9999002224.SGD","LU1951198990.SGD","LU2462591350.SGD","SG9999015978.USD","LU1880383366.USD","BK4549","LU1769817096.USD","LU1642822529.SGD","VT","FAI","89888","LU0039217434.USD","LU2237443895.HKD","LU0516423091.SGD","LFGY","IE00BDRTCR15.USD","IE0004445015.USD","NULC","LU2929501877.USD","01797","01952","LU0359202008.SGD","LU2237438978.USD","BK4612","LU0463099449.HKD","LU1989772923.USD","LU2065169927.USD","LU2065171311.SGD","LU1778281490.HKD","LU1069347547.HKD","LU0234572021.USD","LU1794554557.SGD","NVII","LU0543330566.HKD","LU0472753341.HKD","BABA","IE00BQXX3F31.USD","SG9999014674.SGD","IE00BK4W5L77.USD","LU1046421795.USD","BK4504","IE00B1XK9C88.USD","LU1839511570.USD","BK1618","LU0211327993.USD","LU1720050803.USD","BK4532","LU0308772762.SGD","LU0831093199.SGD","LU0823434583.USD","02268","LU0006306889.USD","XLK","LU1813983027.USD","LU0251132253.USD","LU2133065610.SGD","LU2326559502.SGD","USD","FDTX","LU0289739343.SGD","BK4524","LU0048584097.USD","LU1633808545.USD","LU2430703095.HKD","LU0359201612.USD","LU0957808578.USD","LU1152091168.USD","LU0444973449.USD","LU0070217475.USD","IE00BQXX3D17.EUR","IE00BFMHRM44.USD","LU0140636845.USD","LU1803068979.SGD","BK4535","IE00BFSS7M15.SGD","LU1548497426.USD","LU2361044865.SGD","KURE","LU2462157665.USD","LU2463028550.USD","LU1429558221.USD","IE00BN29S564.USD","LU1670756490.USD","CMAG","LU0918141887.USD","BK4527","IE00B0JY6N72.USD","LU2168564149.EUR","LU2413666699.HKD","BK1191","VGT","LU2417539215.USD","LU2746668974.SGD","LU0738911758.USD","LU0553294199.USD","NVD2.UK","LU2039709279.SGD","LU2750360997.AUD","LU0274383776.USD","LU1515016050.SGD","IE0009G5SDU7.USD","LU2023250504.SGD","LU1261432733.SGD","LU0164865239.USD","LU1481107354.HKD","02269","NVDB","IE0004086264.USD","LU0164880469.USD","LU0314109678.HKD","BK4533","LU1400636574.HKD","LU0320764599.SGD","BK1583","LU0353189680.USD","LU1046422090.SGD","LU0128525929.USD","688331","LU0316494557.USD","LU1674673428.USD","LU0320765059.SGD","LU1969619763.USD","LU0648948544.HKD","LU0588546209.SGD","LU2077746001.SGD","07788","LU2023250330.USD","SG9999015986.USD","LU1721428933.USD","LU2168563687.JPY","LU2462591277.SGD","LU0082616367.USD","BK1588","IXN","BK1615","LU0265550946.USD","LU1105468828.SGD","LU2125909916.SGD","CNEQ","ALBmain","LU0265550359.USD","LU0267386448.USD","LU1066051225.USD","BABW","ABFL","BK1589","LU0390134368.USD","LU2054465674.USD","LU2168564065.EUR","IETC","LU2403377893.USD","LU0965509101.SGD","NVIW.SI","TTEQ","LU2322448791.USD","NVYY","LU2394011477.USD","LU2413666426.HKD","ILDR","LU1914381329.SGD","LU0689472784.USD","IE00BHPRN162.USD","LU1935043023.USD","LU1861127337.USD","LU1003077747.HKD","LU1035773651.USD","LU1718418525.SGD","LU0307460666.USD","LU2087625088.SGD","LU0061474960.USD","SG9999006597.SGD","SG9999017495.SGD","LU0047713382.USD","LU0889565833.HKD","LU0531971595.HKD","GB00BDT5M118.USD","LU2111349929.HKD","NVD3.UK","BK1170","IE00BJTD4N35.SGD","LU0345769631.USD","LU2125154935.USD","IE000YTNTUN2.SGD","LU0985320562.USD","BK4538","JGRO","SMHX","BK1575","LU1861215975.USD","IE00B775SV38.USD","LU2381873111.SGD","LU1868836591.USD","BK4503","LU0149721374.USD","LU2211815571.USD","BK4531","LU1051768304.USD","LU0053666078.USD","LU2106854487.HKD","LU1282649067.USD","LU2237443622.USD","SG9999004303.SGD","BK4588","LU0823421333.USD","LU2237443549.SGD","LU0276348264.USD","LU0080751232.USD","LU2931357623.SGD","LU0128526141.USD","LU0651947912.USD","LU2361045086.USD","LU2028103732.USD","LU2148611432.USD","IE00BJJMRX11.SGD","CHPX","LU1674673691.USD","LU0154236417.USD","LU0210528500.USD","LU1188198961.HKD","02556","LU1037948897.HKD","LU0516422366.SGD","LU1629891620.HKD","LU2089283258.USD","SG9999015945.SGD","BK1144","LU2237443978.SGD","LU1712237335.SGD","WXXWY","IE00BZ1G4Q59.USD","BK1523","LU1720051017.SGD","LU0197773160.USD","LU1868837300.USD","LU0173614495.USD","IE00B3SWFQ91.USD","LU0128525689.USD","BK1509","LU0210533765.USD","LU2954938101.SGD","LU2279689827.SGD","LU2272731782.SGD","SOXX","SG9999018857.SGD","LU1923622291.USD","HK0000532082.HKD","LU1935042215.USD","LU0174119429.USD","SG9999002562.SGD","BK1596","LU2226246903.HKD","LU0630378692.HKD","WISE","IE00BJLML261.HKD","LU0345769128.USD","LU0918141705.HKD","BK1228","LU0719512351.SGD","LU1880398471.USD","LU2778985437.USD","LU0072913022.USD","NVDS.UK","LU1983260115.SGD","LU0323239441.USD","SG9999018865.SGD","LU0501845795.SGD","LU1821325948.USD","LU2756315318.SGD","LU0476273544.USD","LU2322448957.HKD","LU0689626769.HKD","BK4575","BK1141","LU0821914370.USD","IE00BMPRXQ63.HKD","LU0011850046.USD","LU1935042991.SGD","LU2433249047.HKD","LU2592432038.USD","LU0328353924.USD","SG9999000418.SGD","BABX","LU0762542818.HKD","LU0061474705.USD","LU0786609619.USD","HK0000306685.HKD","LU1791710582.SGD","SGXZ81514606.USD","NVDY","BK1610","LU1868836914.USD","3NVD.UK","LU0266013472.USD","LU0348735423.USD","LU0795875086.SGD","LU2430703251.USD","BABC","IE00BJTD4V19.USD","LU1328277881.USD","LU0640476718.USD","002821","IE00B19Z8W00.USD","LU1974910355.USD","LU3102509885.SGD","LU1989764748.USD","LU2168564495.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181738748","title":"Everest Med Surges Over 17% in Afternoon Trade as Core Drug Nefecon Drives Strong Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1181738748","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181738748?lang=en_us&edition=fundamental","pubTime":"2026-08-25 14:00","pubTimestamp":1787637630,"startTime":"0","endTime":"0","summary":"Shares of EVEREST MED (01952) extended their gains sharply in the afternoon session, with the stock climbing 17.24% to HK$36.46 at the time of writing, on trading volume of HK$831.8 million.The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","01952","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139947123","title":"Midday Market Snapshot: Hang Seng Index Slips 0.25% in Morning Session, Mainland Property Stocks Rally Broadly","url":"https://stock-news.laohu8.com/highlight/detail?id=1139947123","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139947123?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:08","pubTimestamp":1787630920,"startTime":"0","endTime":"0","summary":"Hong Kong stocks opened the session with a mixed tone, as the benchmark Hang Seng Index eased 64 points, or 0.25%, to settle at 25,453 points by the midday break. The Hang Seng Tech Index followed...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","BK1583","LU0588546209.SGD","06821","03067","02610","03037","07300","002821","BK1170","BK1240","BK1544","07500","BK1175","BK1191","03419","01952","BK1172","600988","02800","01548","01918","HK0000320223.HKD","BK1141","BK1574","LU0702159343.USD","NGCRY","BK1161","09115","HSI","03115","HSImain","HK0000306701.USD","02837","03347","KBDCY","BK1222","BK1610","03918","02276","SG9999006597.SGD","07200","02007","BK1523","BK1555","BK1198","BK1506","HSTECH","00081","03088","03330","06693","BK1589","01167","HTImain","FPA","03417","MCHmain","300347","03033","BK1521","HK0000320264.USD","09088","LU0307460666.USD","07226","BK1507","601869","HHImain","LU1166156734.SGD","03423","09067","00148","CTRYY","HK0000306685.HKD","03032","BK1592","83115","BK1149","LU0702159699.USD","02833","06869","513600","07552","82800"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181547517","title":"Movement Alert｜EVEREST MED Rises 5.14% in Regular Trading, mRNA Catalyst Sustains as Broker Reaffirms Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1181547517","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181547517?lang=en_us&edition=fundamental","pubTime":"2026-08-25 09:43","pubTimestamp":1787622224,"startTime":"0","endTime":"0","summary":"On August 25, EVEREST MED rose 5.14% in regular trading, trading at HK$32.56/share, with turnover of HK$118 million. The stock continued its technical recovery following a two-day correction of over...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"EVEREST MED Jumps as Broker Reaffirms Buy on mRNA Platform","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167515089","title":"mRNA Sector Marks Historic Clinical Win, Everest Medicines' Self-Developed Pipeline Gains Prominence","url":"https://stock-news.laohu8.com/highlight/detail?id=1167515089","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167515089?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:52","pubTimestamp":1787583127,"startTime":"0","endTime":"0","summary":"On August 19, Moderna and Merck jointly unveiled positive topline results from the global Phase III INTerpath-001 study evaluating the individualized neoantigen mRNA therapy intismeran autogene...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","BK1583","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167867730","title":"Movement Alert｜EVEREST MED Rises 5.28% in Regular Trading, Technical Rebound as mRNA Catalyst Lingers and Broker Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1167867730","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167867730?lang=en_us&edition=fundamental","pubTime":"2026-08-24 09:35","pubTimestamp":1787535329,"startTime":"0","endTime":"0","summary":"On August 24, EVEREST MED rose 5.28% in regular trading, trading at HK$32.76/share, with turnover of HK$120 million.The stock experienced a technical rebound after two consecutive sessions of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"EVEREST MED Rises as BOCOM Keeps Buy, Nefecon Sales Soar","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147915715","title":"Movement Alert｜EVEREST MED Intraday Decline 6.77%, Profit-Taking After Previous Session mRNA-Fueled 41% Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1147915715","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147915715?lang=en_us&edition=fundamental","pubTime":"2026-08-21 09:32","pubTimestamp":1787275963,"startTime":"0","endTime":"0","summary":"On August 21, EVEREST MED fell 6.77% in regular trading, trading at approximately 31.34 HKD per share, with turnover of 67.08 million HKD. The decline reflects clear profit-taking following the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Bocom Keeps Buy on EVEREST MED After 6.77% Pullback","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661256976","title":"Everest Medicines Limited (HKG:1952) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2661256976","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661256976?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:51","pubTimestamp":1787266310,"startTime":"0","endTime":"0","summary":"It's been a pretty great week for Everest Medicines Limited ( HKG:1952 ) shareholders, with its shares surging 18% to...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1952/everest-medicines-shares/news/everest-medicines-limited-hkg1952-interim-results-just-came","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1952/everest-medicines-shares/news/everest-medicines-limited-hkg1952-interim-results-just-came","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MDCO","VOTE","BK1583","DECU","BK1161","01952","VGFPF","GXDW","FEBU","JOYT","PMDE","BK1574","RGLO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141009336","title":"Medical Stocks Surge on Breakthrough News: Everest Med Jumps Over 70% Intraday, Wuxi Apptec Hits New High, and ETFs See Explosive Volume","url":"https://stock-news.laohu8.com/highlight/detail?id=1141009336","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141009336?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:31","pubTimestamp":1787225510,"startTime":"0","endTime":"0","summary":"A major breakthrough in cancer vaccine development sent pharmaceutical stocks across A-share and Hong Kong markets into overdrive on August 20, with the sector leading all others throughout the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1808992512.USD","BK1576","LU2045819591.USD","LU0052750758.USD","01952","IE00B5MMRT66.SGD","LU1303224171.USD","LU2328871848.SGD","LU1997245094.SGD","LU0708995583.HKD","LU1934453819.USD","LU0320764599.SGD","LU0327786744.USD","LU0700851271.USD","520880","BK1515","BK1161","02359","603259","LU0348766576.USD","LU2125910500.SGD","LU0348767384.USD","LU2495084118.USD","FDN","LU0572944931.SGD","LU1251922891.USD","IE00B543WZ88.USD","BK4585","BK1574","BK0216","LU2242644610.SGD","BK1141","LU2488822045.USD","BK4550","159938","IE00BPRC5H50.USD","BK1583","LU0611395673.USD","LU1719994722.HKD","LU1969619763.USD","BK4588","LU1046422090.SGD","LU0456842615.SGD","LU1979443071.USD","09939","LU1997245177.USD","LU1770034418.SGD","LU1997244956.HKD","LU0469268626.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190878504","title":"HK Movers | Pharma Stocks Surge With 3D Medicines up 68%, CanSino Biologics up 52%","url":"https://stock-news.laohu8.com/highlight/detail?id=1190878504","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190878504?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:55","pubTimestamp":1787190950,"startTime":"0","endTime":"0","summary":"Pharma stocks surged in Hong Kong. $3D Medicines(01244)$ rose 68%; $CanSino Biologics(06185)$ rose 52%; $Everest Medicines(01952)$ rose 48%; $Metis TechBio(07666)$ rose 30%; $AIM Vaccine(06660)$ rose 21%.  ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"330240692f324d079ccf839d9e4180bf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","01244","07666","06185","06660"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.everestmedicines.com","stockEarnings":[{"period":"1week","weight":-0.1198},{"period":"1month","weight":0.2961},{"period":"3month","weight":0.1293},{"period":"6month","weight":-0.1159},{"period":"1year","weight":-0.4925},{"period":"ytd","weight":-0.1217}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":-0.0247},{"period":"3month","weight":0.0101},{"period":"6month","weight":-0.0211},{"period":"1year","weight":-0.0051},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Everest Medicines Ltd is a biopharmaceutical company primarily engaged in the discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines. The Company has built a product pipeline across renal, anti-infective, and autoimmune diseases. The Company’s products portfolio includes Nefecon (TARPEYO) using in the renal therapeutic area, XERAVA (eravacycline) using in the treatment of infections caused by susceptible gram-positive, gram-negative and anaerobic pathogens including those multidrug resistant isolates and other products. The Company conducts its business in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.01035},{"month":2,"riseRate":0.333333,"avgChangeRate":0.039331},{"month":3,"riseRate":0.333333,"avgChangeRate":0.002002},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.092533},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.045773},{"month":6,"riseRate":0.666667,"avgChangeRate":0.224714},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.090363},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.046758},{"month":9,"riseRate":0.5,"avgChangeRate":0.038469},{"month":10,"riseRate":0.4,"avgChangeRate":-0.024036},{"month":11,"riseRate":0.5,"avgChangeRate":0.086142},{"month":12,"riseRate":0.666667,"avgChangeRate":0.131823}],"exchange":"SEHK","name":"EVEREST MED","nameEN":"EVEREST MED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"EVEREST MED(01952),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest EVEREST MED(01952) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"EVEREST MED,01952,EVEREST MED股票,EVEREST MED股票老虎,EVEREST MED股票老虎国际,EVEREST MED行情,EVEREST MED股票行情,EVEREST MED股价,EVEREST MED股市,EVEREST MED股票价格,EVEREST MED股票交易,EVEREST MED股票购买,EVEREST MED股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"EVEREST MED(01952),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest EVEREST MED(01952) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}